Sanuwave Health (NASDAQ:SNWV) Lowered to Buy Rating by Wall Street Zen

Wall Street Zen cut shares of Sanuwave Health (NASDAQ:SNWV) from a strong-buy rating to a buy rating in a research report report published on Sunday morning.

SNWV has been the topic of a number of other reports. Northland Capmk upgraded Sanuwave Health to a “strong-buy” rating in a research note on Wednesday, September 3rd. Northland Securities began coverage on shares of Sanuwave Health in a research report on Wednesday, September 3rd. They set an “outperform” rating and a $55.00 target price for the company. Finally, Roth Capital boosted their price target on shares of Sanuwave Health from $54.00 to $55.00 and gave the company a “buy” rating in a research report on Friday, August 22nd. One analyst has rated the stock with a Strong Buy rating and two have assigned a Buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $55.00.

Sanuwave Health Stock Performance

Shares of SNWV stock opened at $36.09 on Friday. Sanuwave Health has a 12-month low of $5.63 and a 12-month high of $46.58. The business’s 50 day moving average is $37.61. The stock has a market cap of $309.29 million, a price-to-earnings ratio of -4.37 and a beta of 1.39.

Sanuwave Health (NASDAQ:SNWV) last announced its quarterly earnings data on Friday, August 8th. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.09) by $0.10. The firm had revenue of $10.16 million for the quarter, compared to the consensus estimate of $10.14 million. Sanuwave Health has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of SNWV. Legal & General Group Plc bought a new position in shares of Sanuwave Health in the second quarter worth $26,000. BNP Paribas Financial Markets bought a new stake in Sanuwave Health during the second quarter valued at $46,000. Strategic Investment Solutions Inc. IL purchased a new position in Sanuwave Health during the first quarter worth about $47,000. Police & Firemen s Retirement System of New Jersey purchased a new position in Sanuwave Health during the second quarter worth about $52,000. Finally, New York State Common Retirement Fund bought a new position in Sanuwave Health in the 2nd quarter worth about $102,000. 42.53% of the stock is owned by institutional investors.

Sanuwave Health Company Profile

SANUWAVE Health, Inc, a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures.